{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:25:05Z","timestamp":1747175105032,"version":"3.40.5"},"reference-count":148,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1053\/j.semnuclmed.2024.10.001","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:02:54Z","timestamp":1730973774000},"page":"827-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-FDG hypoxia tracers"],"prefix":"10.1053","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3784-4090","authenticated-orcid":false,"given":"Kgomotso M.G","family":"Mokoala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-0625","authenticated-orcid":false,"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"1035","key":"10.1053\/j.semnuclmed.2024.10.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0003","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","article-title":"Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia","volume":"15","author":"Carreau","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0004","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/02841860410026189","article-title":"Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer","volume":"43","author":"Nordsmark","year":"2004","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(00)01493-0","article-title":"Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma","volume":"49","author":"Nordsmark","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(03)00010-0","article-title":"Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas","volume":"67","author":"Nordsmark","year":"2003","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0007","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0360-3016(00)00803-8","article-title":"Pancreatic tumors show high levels of hypoxia","volume":"48","author":"Koong","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0008","first-page":"142","article-title":"Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva","volume":"27","author":"Vaupel","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/0-387-26206-7_44","article-title":"Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion","volume":"566","author":"Vaupel","year":"2005","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0011","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4615-3428-0_14","article-title":"Blood flow and tissue oxygenation of human tumors: an update","volume":"317","author":"Vaupel","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(04)81023-1","article-title":"Tumor hypoxia and malignant progression","volume":"381","author":"Vaupel","year":"2004","journal-title":"Methods Enzymol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.990013","article-title":"Editorial: Hypoxia in cardiovascular disease","volume":"9","author":"Bilo","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","article-title":"Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104015","article-title":"Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development","volume":"29","author":"Ahmed","year":"2024","journal-title":"Drug Discovery Today"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0016","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1212\/WNL.54.2.362","article-title":"Hypoxia, hyperoxia, ischemia, and brain necrosis","volume":"54","author":"Miyamoto","year":"2000","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.712317","article-title":"Hypoxia-induced neuroinflammation in Alzheimer's disease: potential neuroprotective effects of centella asiatica","volume":"12","author":"Hambali","year":"2021","journal-title":"Front Physiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0018","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/1673-5374.290898","article-title":"Hypoxia in Alzheimer's disease: effects of hypoxia inducible factors","volume":"16","author":"Hassan","year":"2021","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0019","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1097\/CCM.0b013e3181a009f8","article-title":"Brain tissue oxygen and outcome after severe traumatic brain injury: a systematic review","volume":"37","author":"Maloney-Wilensky","year":"2009","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamaneurol.2016.0251","article-title":"Brain hypoxia and ischemia after traumatic brain injury: is oxygen the right metabolic target?","volume":"73","author":"Vespa","year":"2016","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0021","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10555-007-9058-y","article-title":"Hypoxia and cancer","volume":"26","author":"Semenza","year":"2007","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.10.001_bib0022","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/iub.93","article-title":"Hypoxia-inducible factor 1 and cancer pathogenesis","volume":"60","author":"Semenza","year":"2008","journal-title":"IUBMB Life"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0023","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumor metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00689633","article-title":"Hypoxia and drug resistance","volume":"13","author":"Teicher","year":"1994","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0026","first-page":"546","volume":"ix","author":"Hall","year":"2006"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/gyno.1993.1262","article-title":"Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix","volume":"51","author":"Hockel","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4615-0205-0_6","article-title":"Oxygenation of cervix cancers: impact of clinical and pathological parameters","volume":"510","author":"Hockel","year":"2003","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0029","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/ars.2007.1623","article-title":"The potential role of intrinsic hypoxia markers as prognostic variables in cancer","volume":"9","author":"Moon","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"19","key":"10.1053\/j.semnuclmed.2024.10.001_bib0030","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0031","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1200\/JCO.2003.11.132","article-title":"Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer","volume":"21","author":"Swinson","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0032","first-page":"51","article-title":"Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia","volume":"80","author":"Ziello","year":"2007","journal-title":"Yale J Biol Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0033","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/0284186X.2010.516274","article-title":"Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode","volume":"49","author":"Mortensen","year":"2010","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0034","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-8140(99)00139-5","article-title":"Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix","volume":"53","author":"Knocke","year":"1999","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0035","first-page":"3316","article-title":"Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements","volume":"51","author":"Vaupel","year":"1991","journal-title":"Cancer Res"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0036","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2307\/3580034","article-title":"Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors","volume":"151","author":"Raleigh","year":"1999","journal-title":"Radiat Res"},{"issue":"23","key":"10.1053\/j.semnuclmed.2024.10.001_bib0037","first-page":"7066","article-title":"Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer","volume":"62","author":"Kaanders","year":"2002","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","article-title":"Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole","volume":"22","author":"Koh","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0039","doi-asserted-by":"crossref","first-page":"21746","DOI":"10.1038\/s41598-022-26199-7","article-title":"Timing of hypoxia PET\/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients","volume":"12","author":"Bourigault","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.112.109330","article-title":"High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer","volume":"54","author":"Okamoto","year":"2013","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0041","first-page":"1921","article-title":"Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET","volume":"47","author":"Cherk","year":"2006","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0042","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00259-002-1096-7","article-title":"[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression","volume":"30","author":"Rajendran","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0043","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2006.07.033","article-title":"Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients","volume":"80","author":"Thorwarth","year":"2006","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0044","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1007\/s00259-006-0175-6","article-title":"FDG\u2013a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer","volume":"33","author":"Zimny","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"10.1053\/j.semnuclmed.2024.10.001_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164101","article-title":"First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer","volume":"13","author":"Thureau","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e3182708777","article-title":"Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET\/CT in suspected or proven pancreatic cancer","volume":"38","author":"Segard","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0047","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/02841860802256434","article-title":"Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG?","volume":"47","author":"Roels","year":"2008","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0048","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2010.10.011","volume":"98","author":"Vera","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0049","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.194.3.7862981","article-title":"Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia","volume":"194","author":"Yang","year":"1995","journal-title":"Radiology"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.10.001_bib0050","first-page":"1397","article-title":"Pharmacokinetics of [18F]FETNIM: a potential marker for PET","volume":"42","author":"Gronroos","year":"2001","journal-title":"J Nucl Med"},{"issue":"40","key":"10.1053\/j.semnuclmed.2024.10.001_bib0051","doi-asserted-by":"crossref","first-page":"e17067","DOI":"10.1097\/MD.0000000000017067","article-title":"Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET\/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome","volume":"98","author":"Hu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0052","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00259-019-04621-z","article-title":"Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole ((18)F-FETNIM) PET\/CT and overall survival in glioma patients","volume":"47","author":"Hu","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0053","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1442-2050.2011.01209.x","article-title":"Measuring tumor hypoxia with (1)(8)F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study","volume":"25","author":"Yue","year":"2012","journal-title":"Dis Esophagus"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0054","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/RLU.0b013e318279fd3d","article-title":"Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET\/CT and immunohistochemical studies in non-small cell lung cancer","volume":"38","author":"Hu","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/RLU.0b013e3182638e7e","article-title":"Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET\/CT","volume":"37","author":"Vercellino","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"supplement 2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0056","first-page":"21","article-title":"Imaging of uterine cervix carcinoma using the hypoxia tracer 18F-FETNIM PET","volume":"51","author":"Moretti","year":"2010","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157606","article-title":"A comparative study of noninvasive hypoxia imaging with 18f-fluoroerythronitroimidazole and 18f-fluoromisonidazole PET\/CT in patients with lung cancer","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0058","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2967\/jnumed.113.122671","article-title":"First Evaluation of PET-Based Human Biodistribution and Dosimetry of (18)F-FAZA, a Tracer for Imaging Tumor Hypoxia","volume":"58","author":"Savi","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0059","first-page":"106","article-title":"Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside","volume":"46","author":"Piert","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lungcan.2015.11.020","article-title":"Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer","volume":"91","author":"Kinoshita","year":"2016","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0061","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0062","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","article-title":"Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer","volume":"69","author":"Grosu","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0063","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00259-015-3247-7","article-title":"Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome","volume":"43","author":"Graves","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0064","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002800100324","article-title":"Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles","volume":"48","author":"Koch","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-002-1037-5","article-title":"Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5","volume":"30","author":"Ziemer","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0066","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0969-8043(00)00102-0","article-title":"[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure","volume":"54","author":"Dolbier","year":"2001","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0067","first-page":"1049","article-title":"Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors","volume":"277","author":"Laughlin","year":"1996","journal-title":"J Pharmacol Exp Ther."},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0068","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/cbr.2011.1130","article-title":"Radiation Dosimetry and Biodistribution of the Hypoxia Tracer 18F-EF5 in Oncologic Patients","volume":"27","author":"Lin","year":"2012","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0069","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2967\/jnumed.108.053785","article-title":"18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer","volume":"49","author":"Komar","year":"2008","journal-title":"J Nucl Med"},{"issue":"2 Suppl 1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0070","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.prro.2013.01.092","article-title":"A pilot study of F18 EF5 PET\/CT imaging in patients with carcinoma of the cervix","volume":"3","author":"Lin","year":"2013","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0071","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2018.03.045","article-title":"18F-EF5 PET-based imageable hypoxia predicts local recurrence in tumors treated with highly conformal radiation therapy","volume":"102","author":"Qian","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0072","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13550-020-00689-z","article-title":"The feasibility of [(18)F]EF5-PET\/CT to image hypoxia in ovarian tumors: a clinical study","volume":"10","author":"Laasik","year":"2020","journal-title":"EJNMMI Res"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.10.001_bib0073","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s00259-010-1517-y","article-title":"Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma","volume":"37","author":"Koch","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.10.001_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139425","article-title":"18F-EF5 PET Is predictive of response to fractionated radiotherapy in preclinical tumor models","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"issue":"35","key":"10.1053\/j.semnuclmed.2024.10.001_bib0075","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1073\/pnas.1102526108","article-title":"Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging","volume":"108","author":"Dubois","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0076","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/MNM.0b013e3283407950","article-title":"Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET\/CT","volume":"31","author":"Doss","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0077","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.113.126615","article-title":"A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers","volume":"55","author":"Carlin","year":"2014","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.10.001_bib0078","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3109\/0284186X.2015.1067721","article-title":"Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia\u2013a simulation study","volume":"54","author":"Wack","year":"2015","journal-title":"Acta Oncol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.10.001_bib0079","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/MNM.0b013e3283571016","article-title":"(1)(8)F-HX4 hypoxia imaging with PET\/CT in head and neck cancer: a comparison with (1)(8)F-FMISO","volume":"33","author":"Chen","year":"2012","journal-title":"Nucl Med Commun"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0080","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s00259-015-3100-z","article-title":"Repeatability of hypoxia PET imaging using [(1)(8)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial","volume":"42","author":"Zegers","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0081","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/0284186X.2017.1400177","article-title":"Non-linear conversion of HX4 uptake for automatic segmentation of hypoxic volumes and dose prescription","volume":"57","author":"Ureba","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109454","article-title":"(18)F-HX4\/(18)F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice","volume":"119","author":"Yu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0083","first-page":"9","article-title":"[(18)F]-HX4 PET\/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials","volume":"23","author":"Sanduleanu","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"13","key":"10.1053\/j.semnuclmed.2024.10.001_bib0084","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/1078-0432.CCR-15-0018","article-title":"TH-302 in combination with radiotherapy enhances the therapeutic outcome and is associated with pretreatment [18F]HX4 hypoxia PET imaging","volume":"21","author":"Peeters","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0085","first-page":"1155","article-title":"Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0086","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0969-8051(98)00049-3","article-title":"Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats","volume":"26","author":"Fujibayashi","year":"1999","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0087","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nucmedbio.2009.11.004","article-title":"Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM","volume":"37","author":"Dearling","year":"2010","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0088","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00259-003-1130-4","article-title":"In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM","volume":"30","author":"Dehdashti","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0089","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0360-3016(02)04477-2","article-title":"Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report","volume":"55","author":"Dehdashti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.107.048520","article-title":"Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone)","volume":"49","author":"Dehdashti","year":"2008","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0091","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00259-004-1756-x","article-title":"Dosimetry of 60\/61\/62\/64Cu-ATSM: a hypoxia imaging agent for PET","volume":"32","author":"Laforest","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0092","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11307-007-0095-2","article-title":"Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix","volume":"9","author":"Grigsby","year":"2007","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0093","first-page":"193","article-title":"Assessing tumor hypoxia by positron emission tomography with Cu-ATSM","volume":"53","author":"Holland","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0094","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2967\/jnumed.108.051326","article-title":"An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix","volume":"49","author":"Lewis","year":"2008","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2967\/jnumed.113.119917","article-title":"A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo","volume":"55","author":"Hueting","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0096","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3174\/ajnr.A3159","article-title":"Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma","volume":"34","author":"Tateishi","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0097","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/RLU.0000000000000537","article-title":"Assessing tumor hypoxia in head and neck cancer by PET with (6)(2)Cu-diacetyl-bis(N(4)-methylthiosemicarbazone)","volume":"39","author":"Sato","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0098","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MNM.0000000000000656","article-title":"Early and delayed evaluation of solid tumours with 64Cu-ATSM PET\/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis","volume":"38","author":"Lopci","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0099","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/RLU.0b013e3182a756f0","article-title":"Usefulness of 64Cu-ATSM in head and neck cancer: a preliminary prospective study","volume":"39","author":"Grassi","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12149-011-0471-5","article-title":"Assessment of tumor hypoxia by 62 Cu-ATSM PET\/CT as a predictor of response in head and neck cancer: a pilot study","volume":"25","author":"Minagawa","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.10.001_bib0101","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s10350-008-9420-3","article-title":"Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study","volume":"51","author":"Dietz","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nucmedbio.2012.11.003","article-title":"Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia","volume":"40","author":"Fernandez","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.10.001_bib0103","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1021\/acs.inorgchem.5b00554","article-title":"Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga","volume":"54","author":"Ramogida","year":"2015","journal-title":"Inorg Chem"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0104","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/jm201611a","article-title":"Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N'-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging","volume":"55","author":"Hoigebazar","year":"2012","journal-title":"J Med Chem"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0105","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bmc.2011.02.041","article-title":"Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers","volume":"19","author":"Hoigebazar","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"17","key":"10.1053\/j.semnuclmed.2024.10.001_bib0106","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jm100545a","article-title":"Synthesis and characterization of nitroimidazole derivatives for 68Ga-labeling and testing in tumor xenografted mice","volume":"53","author":"Hoigebazar","year":"2010","journal-title":"J Med Chem"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0107","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cmmi.1649","article-title":"[(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia","volume":"10","author":"Wu","year":"2015","journal-title":"Contrast Media Mol Imaging"},{"issue":"24","key":"10.1053\/j.semnuclmed.2024.10.001_bib0108","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1016\/j.bmc.2015.11.024","article-title":"Development of (68)Ga-labeled multivalent nitroimidazole derivatives for hypoxia imaging","volume":"23","author":"Seelam","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0109","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11040962","article-title":"A prospective investigation of tumor hypoxia imaging with (68)Ga-nitroimidazole PET\/CT in patients with carcinoma of the cervix uteri and comparison with (18)F-FDG PET\/CT: correlation with immunohistochemistry","volume":"11","author":"Mokoala","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jmrs.603","article-title":"(68) Ga-nitroimidazole PET\/CT imaging of hypoxia in tuberculosis: A case series","volume":"69","author":"Bresser","year":"2022","journal-title":"J Med Radiat Sci"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0111","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/MNM.0000000000001580","article-title":"PET\/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study","volume":"43","author":"Bresser","year":"2022","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0112","article-title":"Advances in PET and MRI imaging of tumor hypoxia","volume":"10","author":"Gouel","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0113","first-page":"247","article-title":"Radionuclide imaging of hypoxia: Where are we now? Special attention to cancer of the cervix uteri","volume":"24","author":"Mokoala","year":"2021","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0114","article-title":"Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0115","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.111.099770","article-title":"PET of hypoxia: current and future perspectives","volume":"53","author":"Carlin","year":"2012","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.10.001_bib0116","doi-asserted-by":"crossref","first-page":"884","DOI":"10.5551\/jat.RV17009","article-title":"The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases","volume":"24","author":"Abe","year":"2017","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0117","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.yjmcc.2011.07.005","article-title":"PET imaging of cardiac hypoxia: opportunities and challenges","volume":"51","author":"Handley","year":"2011","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0118","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.RES.67.1.240","article-title":"Fluoromisonidazole. A metabolic marker of myocyte hypoxia","volume":"67","author":"Martin","year":"1990","journal-title":"Circ Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCIMAGING.113.001084","article-title":"Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using 18f-fluoromisonidazole positron emission tomographic imaging","volume":"7","author":"Mateo","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"14","key":"10.1053\/j.semnuclmed.2024.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.jacc.2017.01.050","article-title":"Vascular imaging with 18f-fluorodeoxyglucose positron emission tomography is influenced by hypoxia","volume":"69","author":"Joshi","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.10.001_bib0121","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jcmg.2014.12.015","article-title":"In vivo imaging of hypoxia in atherosclerotic plaques in humans","volume":"8","author":"Valk","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0122","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009791","article-title":"(64)Cu-ATSM positron emission tomography\/magnetic resonance imaging of hypoxia in human atherosclerosis","volume":"13","author":"Nie","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0123","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s13105-022-00912-6","article-title":"Hypoxia: molecular pathophysiological mechanisms in human diseases","volume":"78","author":"Della Rocca","year":"2022","journal-title":"J Physiol Biochem"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.10.001_bib0124","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.28229","article-title":"Signs of chronic hypoxia suggest a novel pathophysiological event in \u03b1-synucleinopathies","volume":"35","author":"Heras-Garvin","year":"2020","journal-title":"Mov Disord"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0125","first-page":"16","article-title":"The relationship between hypoxia and Alzheimer's disease: an updated review","author":"Tao","year":"2024","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0126","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/STROKEAHA.107.485938","article-title":"Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke","volume":"39","author":"Takasawa","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0127","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.neuroimage.2003.11.020","article-title":"Penumbral topography in human stroke: methodology and validation of the 'Penumbragram'","volume":"21","author":"Markus","year":"2004","journal-title":"Neuroimage"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.10.001_bib0128","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1212\/WNL.51.6.1617","article-title":"Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole","volume":"51","author":"Read","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/1531-8249(200008)48:2<228::AID-ANA13>3.0.CO;2-B","article-title":"The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke","volume":"48","author":"Read","year":"2000","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/nimg.2002.1056","article-title":"Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke","volume":"16","author":"Markus","year":"2002","journal-title":"Neuroimage"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.10.001_bib0131","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaneurol.2016.0091","article-title":"Pathophysiologic mechanisms of cerebral ischemia and diffusion hypoxia in traumatic brain injury","volume":"73","author":"Veenith","year":"2016","journal-title":"JAMA Neurology"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fphy.2014.00012","article-title":"Quantitative preclinical PET imaging: opportunities and challenges","volume":"2","author":"Kuntner","year":"2014","journal-title":"Frontiers in Physics"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.10.001_bib0133","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00330-006-0431-y","article-title":"Imaging oxygenation of human tumours","volume":"17","author":"Padhani","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0134","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1102\/1470-7330.2005.0103","article-title":"Where are we with imaging oxygenation in human tumours?","volume":"5","author":"Padhani","year":"2005","journal-title":"Cancer Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.10.001_bib0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.media.2013.05.005","article-title":"Denoising of PET images by combining wavelets and curvelets for improved preservation of resolution and quantitation","volume":"17","author":"Le Pogam","year":"2013","journal-title":"Med Image Anal"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0136","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1016\/j.nima.2010.11.092","article-title":"Fundamental limits of spatial resolution in PET. nuclear instruments and methods in physics research section a: accelerators, spectrometers","volume":"648","author":"Moses","year":"2011","journal-title":"Detectors and Associated Equipment"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0137","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","article-title":"Positron emission tomography: current challenges and opportunities for technological advances in clinical and preclinical imaging systems","volume":"17","author":"Vaquero","year":"2015","journal-title":"Annu Rev Biomed Eng"},{"issue":"22","key":"10.1053\/j.semnuclmed.2024.10.001_bib0138","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1088\/0031-9155\/61\/22\/7957","article-title":"Quantifying hypoxia in human cancers using static PET imaging","volume":"61","author":"Taylor","year":"2016","journal-title":"Phys Med Biol"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.10.001_bib0139","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1118\/1.597506","article-title":"A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data","volume":"22","author":"Casciari","year":"1995","journal-title":"Med Phys"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.10.001_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients","volume":"36","author":"Rasey","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.10.001_bib0141","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1088\/0031-9155\/54\/10\/008","article-title":"Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging","volume":"54","author":"Wang","year":"2009","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.10.001_bib0142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00259-020-04843-6","article-title":"Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives","volume":"48","author":"Dimitrakopoulou-Strauss","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.10.001_bib0143","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.semnuclmed.2021.10.002","article-title":"Parametric Imaging With Dynamic PET for Oncological Applications: Protocols, Interpretation, Current Applications and Limitations for Clinical Use","volume":"52","author":"Dimitrakopoulou-Strauss","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.10.001_bib0144","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1007\/s00259-023-06222-3","article-title":"Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies","volume":"50","author":"Dimitrakopoulou-Strauss","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.10.001_bib0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/17434440.2022.2141111","article-title":"Long axial field-of-view PET\/CT devices: are we ready for the technological revolution?","volume":"19","author":"Filippi","year":"2022","journal-title":"Expert Rev Med Devices"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.10.001_bib0146","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20030267","article-title":"Regulation of the chemokine receptor CXCR4 by hypoxia","volume":"198","author":"Schioppa","year":"2003","journal-title":"J Exp Med"},{"issue":"15","key":"10.1053\/j.semnuclmed.2024.10.001_bib0147","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153953","article-title":"Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1alpha Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept","volume":"15","author":"Mokoala","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.semnuclmed.2024.10.001_bib0148","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.radonc.2020.10.016","article-title":"Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures","volume":"153","author":"Sanduleanu","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299824000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:24:11Z","timestamp":1731723851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299824000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":148,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0001299824000874"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.10.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"type":"print","value":"0001-2998"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-FDG hypoxia tracers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}